Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 4751 - 4775 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Simple Glc series LMSP05010038
  • FMC-6(d18:1/22:0(2-OH))
  • N-(2-hydroxy-docosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
 52931249 1009.706559 C56H99NO14
Diacylglycerophosphoinositolglycans LMGP15010041
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/16:2(9Z,12Z))
 126457409 1008.578658 C50H89O18P
Diacylglycerophosphoinositolglycans LMGP15010046
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/16:1(9Z))
 126457414 1008.578658 C50H89O18P
Diacylglycerophosphoinositolglycans LMGP15010047
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/16:2(9Z,12Z))
 126457415 1006.563008 C50H87O18P
Simple Glc series LMSP0501AB19
  • LacCer(d18:0/26:0)
  • N-(hexacosanoyl)-1-beta-lactosyl-sphinganine
 52931269 1003.789894 C56H109NO13
LMSL03000004
  • 2-O-hexadecanoyl-3-O-(2R,4S,6S-trimethyl-3R-hydroxy-pentacosanoyl)-alpha,alpha-trehalose
  • DAT(16:0/25:0(2Me[R],3OH[R],4Me[S],6Me[S]))
 52929841 1002.75826 C56H106O14
LMSL03000009
  • 2-O-octadecanoyl-3-O-(2R,4S,6S-trimethyl-3R-hydroxy-tricosanoyl)-alpha,alpha-trehalose
  • DAT(18:0/23:0(2Me[R],3OH[R],4Me[S],6Me[S]))
 52929846 1002.75826 C56H106O14
Simple Glc series LMSP0501AB08
  • LacCer(d18:1/26:0)
  • N-(hexacosanoyl)-1-b-lactosyl-sphing-4-enine
 71728418 75340 1001.774244 C56H107NO13
Simple Glc series LMSP0501AB20
  • LacCer(d18:0/26:1)
  • N-(17Z-hexacosenoyl)-1-beta-lactosyl-sphinganine
 52931270 1001.774244 C56H107NO13
Simple Glc series LMSP0501AD06
  • Manbeta1-4Glcbeta-Cer(d18:1/26:0)
 44260161 1001.774244 C56H107NO13
Gal- (Gala series) LMSP0509AA06
  • Galalpha1-4Galbeta-Cer(d18:1/26:0)
 44261961 1001.774244 C56H107NO13
LMSL03000021
  • 2-O-nonadecanoyl-3-O-(2S,4S-dimethyl-tetracosanoyl)-alpha,alpha-trehalose
  • DAT(19:0/24:0(2Me[S],4Me[S]))
 52929858 1000.778995 C57H108O13
Diacylglycerophosphoinositolglycans LMGP15010006
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:0)
 126457374 1000.609958 C49H93O18P
Diacylglycerophosphoinositolglycans LMGP15010015
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:0)
 126457383 1000.609958 C49H93O18P
Diacylglycosylglycerophospholipids LMGP14010010
  • 1-eicosanoyl-2-pentadecanoyl-sn-glycero-3-phospho-(1'-glycerol-3'-)5-deoxy-5-(dimethylarsinyl)-beta-D-ribofuranoside
  • As-PL(20:0/15:0)
 1000.559719 C48H94O14PAs
Diacylglycosylglycerophospholipids LMGP14010014
  • 1-hexadecanoyl-2-nonadecanoyl-sn-glycero-3-phospho-(1'-glycerol-3'-)5-deoxy-5-(dimethylarsinyl)-beta-D-ribofuranoside
  • As-PL(16:0/19:0)
 1000.559719 C48H94O14PAs
Simple Glc series LMSP0501AB10
  • LacCer(d18:1/26:1(17Z))
  • N-(17Z-hexacosenoyl)-1-b-lactosyl-sphing-4-enine
 90659841 84806 999.758594 C56H105NO13
Simple Glc series LMSP0501AD08
  • Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44260163 999.758594 C56H105NO13
Gal- (Gala series) LMSP0509AA08
  • Galalpha1-4Galbeta-Cer(d18:1/26:1(17Z))
 44261963 999.758594 C56H105NO13
Diacylglycerophosphoinositolglycans LMGP15010007
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:1(9Z))
 126457375 998.594308 C49H91O18P
Diacylglycerophosphoinositolglycans LMGP15010016
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:1(9Z))
 126457384 998.594308 C49H91O18P
Diacylglycerophosphoinositolglycans LMGP15010021
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/16:0)
 126457389 998.594308 C49H91O18P
Diacylglycerophosphoinositolglycans LMGP15010017
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:2(9Z,12Z))
 126457385 996.578658 C49H89O18P
Diacylglycerophosphoinositolglycans LMGP15010022
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/16:1(9Z))
 126457390 996.578658 C49H89O18P
Diacylglycerophosphoinositolglycans LMGP15010027
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/16:0)
 126457395 996.578658 C49H89O18P
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024